Financials

News Ideas Discussions Technicals Forecast Seasonals

SYRS fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Syros Pharmaceuticals, Inc.

Total assets of SYRS for Q3 24 is 85.00 M USD, 20.36% less than the previous Q2 24. And total liabilities decreased by 15.00% in Q3 24 to 96.12 M USD.

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—